Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 30, 2003

 

Commission file number: 0-21154

 

CREE, INC.

(Exact name of registrant as specified in its charter)

 

North Carolina

 

56-1572719

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

4600 Silicon Drive

   

Durham, North Carolina

 

27703

(Address of principal executive offices)

 

(Zip Code)

 

(919) 313-5300

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ¨  No

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    x  Yes    ¨  No

 

The number of shares outstanding of the registrant’s common stock, par value $0.00125 per share, as of April 17, 2003 was 73,294,925.

 



Table of Contents

 

CREE, INC.

FORM 10-Q

 

For the Quarter Ended March 30, 2003

 

INDEX

 

          

Page No.


PART I.    FINANCIAL INFORMATION

Item 1.

 

Financial Statements

      
   

Consolidated Balance Sheets at March 30, 2003 (unaudited) and June 30, 2002

    

3

   

Consolidated Statements of Operations for the three and nine months ended March 30, 2003 and March 24, 2002 (unaudited)

    

4

   

Consolidated Statements of Cash Flow for the nine months ended March 30, 2003 and March 24, 2002 (unaudited)

    

5

   

Notes to Consolidated Financial Statements (unaudited)

    

6

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

    

22

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

    

37

Item 4.

 

Controls and Procedures

    

37

PART II.    OTHER INFORMATION

Item 6.

 

Exhibits and Reports on Form 8-K

    

38

   

SIGNATURES

    

39

   

CERTIFICATIONS

    

40

 

2


Table of Contents

 

PART I—FINANCIAL INFORMATION

Item 1—Financial Statements

 

CREE, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

 

    

March 30,

2003


    

June 30,

2002


 
    

(Unaudited)

        

ASSETS

                 

Current assets:

                 

Cash and cash equivalents

  

$

52,152

 

  

$

73,744

 

Short-term investments held to maturity

  

 

69,562

 

  

 

32,396

 

Marketable securities available for sale

  

 

—  

 

  

 

6,008

 

Accounts receivable, net

  

 

36,890

 

  

 

34,592

 

Interest receivable

  

 

5,086

 

  

 

2,083

 

Inventories, net

  

 

17,636

 

  

 

17,966

 

Deferred income taxes

  

 

2,305

 

  

 

1,122

 

Prepaid expenses and other current assets

  

 

5,848

 

  

 

5,994

 

    


  


Total current assets

  

 

189,479

 

  

 

173,905

 

Property and equipment, net

  

 

237,875

 

  

 

211,685

 

Long-term investments held to maturity

  

 

67,292

 

  

 

64,225

 

Deferred income taxes

  

 

18,014

 

  

 

27,365

 

Patent and license rights, net

  

 

6,817

 

  

 

4,251

 

Other assets

  

 

19,897

 

  

 

22,764

 

    


  


Total assets

  

$

539,374

 

  

$

504,195

 

    


  


LIABILITIES AND SHAREHOLDERS’ EQUITY

                 

Current liabilities:

                 

Accounts payable, trade

  

$

16,393

 

  

$

13,075

 

Accrued salaries and wages

  

 

5,953

 

  

 

4,010

 

Deferred revenue and other accrued expenses

  

 

7,050

 

  

 

4,969

 

    


  


Total current liabilities

  

 

29,396

 

  

 

22,054

 

Long term liabilities:

                 

Other long term liabilities

  

 

31

 

  

 

37

 

    


  


Total long term liabilities

  

 

31

 

  

 

37

 

Shareholders’ equity:

                 

Preferred stock, par value $0.01; 3,000 shares authorized at March 30, 2003 and June 30, 2002; none issued and outstanding

  

 

—  

 

  

 

—  

 

Common stock, par value $0.00125; 200,000 shares authorized; 73,290 and 72,729 shares issued and outstanding at March 30, 2003 and June 30, 2002, respectively

  

 

91

 

  

 

90

 

Additional paid-in-capital

  

 

512,399

 

  

 

508,432

 

Deferred compensation expense

  

 

(332

)

  

 

(696

)

Accumulated deficit

  

 

(2,211

)

  

 

(25,722

)

    


  


Total shareholders’ equity

  

 

509,947

 

  

 

482,104

 

    


  


Total liabilities and shareholders’ equity

  

$

539,374

 

  

$

504,195

 

    


  


 

The accompanying notes are an integral part of the consolidated financial statements.

 

3


Table of Contents

 

CREE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

    

Three Months Ended


    

Nine Months Ended


 
    

March 30,

2003


    

March 24,

2002


    

March 30,

2003


  

March 24,

2002


 

Revenue:

                                 

Product revenue, net

  

$

53,774

 

  

$

28,566

 

  

$

145,149

  

$

104,017

 

Contract revenue, net

  

 

6,449

 

  

 

4,810

 

  

 

20,612

  

 

13,617

 

    


  


  

  


Total revenue

  

 

60,223

 

  

 

33,376

 

  

 

165,761

  

 

117,634

 

Cost of revenue:

                                 

Product revenue

  

 

27,018

 

  

 

21,835

 

  

 

79,662

  

 

60,255

 

Contract revenue

  

 

5,158

 

  

 

3,164

 

  

 

15,824

  

 

9,722

 

    


  


  

  


Total cost of revenue

  

 

32,176

 

  

 

24,999

 

  

 

95,486

  

 

69,977

 

    


  


  

  


Gross profit

  

 

28,047

 

  

 

8,377

 

  

 

70,275

  

 

47,657

 

Operating expenses:

                                 

Research and development

  

 

8,138

 

  

 

9,327

 

  

 

22,369

  

 

20,181

 

Sales, general and administrative

  

 

6,712

 

  

 

6,534

 

  

 

20,993

  

 

17,848

 

Other expense

  

 

—  

 

  

 

77,434

 

  

 

1,891

  

 

97,104

 

Goodwill and intangible asset amortization

  

 

—  

 

  

 

2,255

 

  

 

—  

  

 

6,765

 

    


  


  

  


Income (loss) from operations

  

 

13,197

 

  

 

(87,173

)

  

 

25,022

  

 

(94,241

)

Other non operating income (loss)

  

 

(29

)

  

 

—  

 

  

 

2,887

  

 

(11,795

)

Interest income

  

 

1,199

 

  

 

1,006

 

  

 

3,863

  

 

4,496

 

    


  


  

  


Income (loss) before income taxes

  

 

14,367

 

  

 

(86,167

)

  

 

31,772

  

 

(101,540

)

Income tax expense (benefit)

  

 

3,735

 

  

 

(17,881

)

  

 

8,261

  

 

(22,339

)

    


  


  

  


Net income (loss)

  

$

10,632

 

  

$

(68,286

)

  

$

23,511

  

$

(79,201

)

    


  


  

  


Earnings (loss) per share:

                                 

Basic

  

$

0.15

 

  

($

0.94

)

  

$

0.32

  

($

1.09

)

    


  


  

  


Diluted

  

$

0.14

 

  

($

0.94

)

  

$

0.31

  

($

1.09

)

    


  


  

  


Shares used in per share calculation:

                                 

Basic

  

 

73,266